Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure

doi:10.4251/wjgo.v13.i2.119

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7588)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

382

WORD

183

HTML

3641

Figures (1-1)

426

Tables (1-5)

311

Sum=4943

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

456

Download

903

Sum=1359

Publishing Process of This Article

Item

Count

Browse

442

Download

844

Sum=1286

Feb 15, 2021 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Feb 15, 2021; 13(2): 119-130
Published online Feb 15, 2021. doi: 10.4251/wjgo.v13.i2.119

Open in New Tab Full Size Figure Download Figure

Figure 1 Timeline and protocol of both treatment groups. CAPOX: Chemotherapy with capecitabine and oxaliplatin; FOLFOX: Chemotherapy with folinic acid, fluorouracil and oxaliplatin.

Citation: Tuta M, Boc N, Brecelj E, Peternel M, Velenik V. Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure. World J Gastrointest Oncol 2021; 13(2): 119-130
URL: https://www.wjgnet.com/1948-5204/full/v13/i2/119.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i2.119